Ind-Swift Ltd.

View in App
9.12 -0.06 ▼-0.7%

09 June 2023, 04:01:00 PM
Volume: 4,343

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indswift.com
Market Cap 49.40 Cr.
Enterprise Value(EV) 1,042.01 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 4.81 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 1.90 Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share -120.25 Trailing Twelve Months Ending 2023-03
Price to Book Value -0.08 Calculated using Price: 9.12
Dividend Yield 0.00 Period Ending 2018-03
No. of Shares Subscribed 5.42 Cr. 54,164,653 Shares
FaceValue 2
About Ind-Swift Ltd.
Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company.

Ind-Swift Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ind-Swift Ltd. Performance

View details >>
1 Day
-0.65%
1 Week
-3.70%
1 Month
+2.24%
3 Month
+16.92%
6 Month
-13.23%
1 Year
-17.69%
2 Year
+93.63%
5 Year
+26.32%
10 Year
+23.24%

Ind-Swift Ltd. Fundamental Ratios

View details >>
3 years 2016-03 2017-03 2018-03
Return on Equity (%)
Return on Capital Employed (%) -22.84 -56.70 -10.34
Return on Assets (%) -18.95 -42.37 -8.46

Ind-Swift Ltd. Balance Sheet

View details >>
Particulars 5 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2022-03* Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds -245 -616 -663 -720 -705
Non Curr. Liab. 679 672 680 634 418
Curr. Liab. 621 608 598 718 936
Minority Int.
Equity & Liab. 1,055 665 615 632 649
Non Curr. Assets 433 458 429 389 376
Curr. Assets 612 206 186 242 273
Misc. Exp. not W/O 10
Total Assets 1,055 665 615 632 649

Ind-Swift Ltd. Profit and Loss

View details >>
Particulars 4 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 304 263 270 411
Other Income 13 14 15 12
Total Income 317 277 284 423
Total Expenditure -461 -328 -264 -369
PBIDT -144 -52 21 54
Interest -19 -16 -11 -60
Depreciation -36 -36 -35 -29
Taxation 0 -1 -1
Exceptional Items -260 -28 61
PAT -200 -364 -54 26
Minority Interest
Share Associate -14 -8 4
Other Related Items
Consolidated Net Profit -214 -373 -50 26
Adjusted EPS -42 -69 -9 5

Ind-Swift Ltd. Cash Flow

View details >>
Particulars 3 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr.
Cash Fr. Operatn. -119 -2 7
Cash Fr. Inv. 10 4 -6
Cash Fr. Finan. 110 -11 -6
Net Change 0 -8 -5
Cash & Cash Eqvt 17 9 4

Ind-Swift Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 55.55 55.55 55.55 55.55 55.58 55.58 55.58 55.58 55.58
Public 44.45 44.45 44.45 44.45 44.42 44.42 44.42 44.42 44.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 73.46 73.46 73.46 73.46 73.43 42.81 42.81 42.81 42.81

Ind-Swift Ltd. Announcements

View details >>
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Financial results for the quarter and financial year ended 31.03.2023
Tue, 30 May 2023
Audited Standalone & Consolidated Financial Results Of Ind-Swift Limited For The Fourth Quarter (Q4) And Financial Year Ended 3 1" March 2023.
Audited Standalone & Consolidated Financial Results of Ind-Swift Limited for the Fourth Quarter (Q4) and Financial Year ended 3 1" March 2023.
Tue, 30 May 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 30.05.2023
Outcome of Board Meeting

Ind-Swift Ltd. Technical Scans

View details >>
Fri, 09 Jun 2023
High Delivery Percentage High Delivery Percentage
High Increase in 3 Months High Increase in 3 Months
High Increase in 2 Years High Increase in 2 Years
Bearish Harami Cross Bearish Harami Cross
Thu, 08 Jun 2023
High Delivery Percentage High Delivery Percentage

Ind-Swift Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Ind-Swift Ltd. FAQ's

What is Ind-Swift share price?
Can I buy Ind-Swift shares now?
What is the Market Cap of Ind-Swift?
What are the key metrics to analyse Ind-Swift?
What is the 52 Week High and Low of Ind-Swift?
What is the trend of Ind-Swift share price?